Last: | $1.82 |
---|---|
Change Percent: | 0.0% |
Open: | $1.72 |
Close: | $1.82 |
High: | $1.83 |
Low: | $1.68 |
Volume: | 118,745 |
Last Trade Date Time: | 04/26/2024 03:00:00 am |
Quotes are delayed by 15 to 20 minutes.
Last | Open | Close | High | Low | Volume | Date |
---|---|---|---|---|---|---|
$1.82 | $1.72 | $1.82 | $1.83 | $1.68 | 118,745 | 04-26-2024 |
$1.72 | $1.72 | $1.72 | $1.74 | $1.66 | 75,594 | 04-25-2024 |
$1.73 | $1.75 | $1.73 | $1.7737 | $1.72 | 60,760 | 04-24-2024 |
$1.75 | $1.72 | $1.75 | $1.8401 | $1.7 | 143,651 | 04-23-2024 |
$1.72 | $1.84 | $1.72 | $1.9 | $1.7 | 207,845 | 04-22-2024 |
$1.84 | $1.89 | $1.84 | $1.95 | $1.84 | 155,092 | 04-19-2024 |
$1.89 | $1.89 | $1.89 | $1.95 | $1.86 | 180,641 | 04-18-2024 |
$1.9 | $1.88 | $1.9 | $1.9437 | $1.82 | 234,274 | 04-17-2024 |
$1.87 | $1.87 | $1.87 | $1.91 | $1.81 | 240,719 | 04-16-2024 |
$1.82 | $1.94 | $1.82 | $1.98 | $1.8136 | 295,929 | 04-15-2024 |
$1.92 | $1.99 | $1.92 | $2.0279 | $1.85 | 320,223 | 04-12-2024 |
$2 | $1.87 | $2 | $2.03 | $1.87 | 303,968 | 04-11-2024 |
$1.87 | $2.11 | $1.87 | $2.11 | $1.75 | 496,658 | 04-10-2024 |
$2.08 | $2.1 | $2.08 | $2.17 | $1.91 | 826,783 | 04-09-2024 |
$2.02 | $1.8 | $2.02 | $2.88 | $1.8 | 12,681,075 | 04-08-2024 |
$1.76 | $1.75 | $1.76 | $1.7669 | $1.69 | 94,463 | 04-05-2024 |
$1.74 | $1.72 | $1.74 | $1.8 | $1.6551 | 106,113 | 04-04-2024 |
$1.7 | $1.68 | $1.7 | $1.72 | $1.64 | 98,182 | 04-03-2024 |
$1.72 | $1.8 | $1.72 | $1.82 | $1.68 | 106,179 | 04-02-2024 |
$1.76 | $1.86 | $1.76 | $1.9 | $1.75 | 71,231 | 04-01-2024 |
News, Short Squeeze, Breakout and More Instantly...
Palatin Technologies Inc. Company Name:
PTN Stock Symbol:
NYSE Market:
Palatin Technologies Inc. Website:
The Dow Jones index closed slightly lower on Thursday. When insiders purchase or sell shares, it indicates their confidence or concern around the c...
On Monday, Palatin Technologies Inc. (NYSE:PTN) announced the presentation of topline results for its Phase 3 PL9643 MELODY-1 trial, whic...
2024-04-08 08:01:14 ET DENVER, Colo., Apr 08, 2024 ( 247marketnews.com )- Palatin Technologies, Inc. (NYSE: PTN ) presented positive Phase 3 PL9643 MELODY-1 clinical trial results for the treatment of dry eye disease (DED) at the American Society of Cataract and Refractive Surgery (...